Ja. Smith et al., PREGNANCY IN SICKLE-CELL DISEASE - EXPERIENCE OF THE COOPERATIVE STUDY OF SICKLE-CELL DISEASE, Obstetrics and gynecology, 87(2), 1996, pp. 199-204
Objective: To determine the maternal and fetal outcomes of pregnancy i
n women with sickle cell disease. Methods: The subjects were part of a
cohort recruited from 19 centers for a prospective study of the clini
cal course of sickle cell disease. Each participant was evaluated usin
g a structured protocol in which steady-state data and information on
both sickle- and non-sickle-related events were collected. The rates o
f antepartum and intrapartum complications were tallied for pregnancie
s carried to delivery. Fetal outcome was assessed according to gestati
onal age, birth weight, and Apgar score. Differences among genotypes i
n event rates were assessed using Fisher exact test. Differences in ge
stational age and birth weight, and predictors of these outcomes, were
assessed using analyses of covariance. Results: Two hundred eighty-si
x of the 445 reported pregnancies proceeded to delivery. Non-sickle-re
lated antepartum and intrapartum complication rates were comparable wi
th those of African-American women who did not have sickle cell diseas
e. One of the two deaths observed during this study was directly relat
ed to the presence of sickle cell disease. Rates of maternal morbidity
from sickle cell disease were the same during pregnancy as during the
nonpregnant state. Ninety-nine percent of those pregnancies carried t
o delivery resulted in a live birth. Twenty-one percent of the infants
born to women of the SS genotype were small for gestational age (SGA)
. Preeclampsia and acute anemic events were identified as risk factors
for SGA infants. Conclusion: Those caring for women with sickle cell
disease should support them if they desire to have children.